...
首页> 外文期刊>The Open Chemical and Biomedical Methods Journal >A Simple Sample Preparation with HPLC–UV Method for Estimation of Amlodipine from Plasma: Application to Bioequivalence Study
【24h】

A Simple Sample Preparation with HPLC–UV Method for Estimation of Amlodipine from Plasma: Application to Bioequivalence Study

机译:HPLC-UV法从血浆中估计氨氯地平的简单样品制备:在生物等效性研究中的应用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A simple, rapid and selective method was developed for the estimation of amlodipine from human plasma. Themethod involves a simple protein precipitation techniques using nifedipine as internal standard. Chromatographic separationwas carried out on a reverse phase C18 column using mixture of 50 mM potassium di hydrogen ortho phosphate (pH7.5) and acetonitrile (60:40, v/v) at a flow rate of 1.0 mL/min with UV detection at 239 nm. The retention time of amlodipineand internal standard were 4.12 and 8.31min, respectively. The method was validated and found to be linear inthe range of 0.5-50.0 ng/mL. An open, randomized, two-treatment, two period, single dose crossover, bioequivalencestudy in 24 fasting, healthy, male, volunteers was conducted. After dosing, serial blood samples were collected for the periodof 168.0 h. Various pharmacokinetic parameters including AUC0-t, AUC0-∞, Cmax, Tmax, T1/2, and elimination rateconstant (Kel) were determined from plasma concentration of both formulations of test (Amlodipine 5 mg tablets) and reference(Amlodipine 5 mg tablets). Log transformed values were compared by analysis of variance (ANOVA) followed byclassical 90% confidence interval for Cmax, AUC0-t, AUC0-∞ and was found to be within the range. These results indicatedthat the analytical method was linear, precise and accurate. Test and reference formulation were found to be bioequivalent.
机译:开发了一种简单,快速和选择性的方法,用于从人血浆中估算氨氯地平。该方法涉及使用硝苯地平作为内标的简单蛋白质沉淀技术。使用50 mM正磷酸二氢钾(pH7.5)和乙腈(60:40,v / v)的混合物,在1.0 C / min的反相C18色谱柱上进行色谱分离,并在239处进行UV检测纳米氨氯地平和内标物的保留时间分别为4.12和8.31min。该方法经过验证,发现线性范围为0.5-50.0 ng / mL。在24名空腹,健康,男性志愿者中进行了开放,随机,两次治疗,两个时期的单剂量交叉,生物等效性研究。给药后,收集连续血样168.0小时。根据测试(氨氯地平5 mg片)和参比物(氨氯地平5 mg片)的血浆浓度确定各种药代动力学参数,包括AUC0-t,AUC0-∞,Cmax,Tmax,T1 / 2和消除速率常数(Kel)。 。通过方差分析(ANOVA),然后是Cmax,AUC0-t,AUC0-∞的经典90%置信区间,比较了对数转换后的值,发现该值在该范围内。这些结果表明该分析方法是线性的,精确的和准确的。发现测试制剂和参考制剂具有生物等效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号